A detailed history of Broderick Brian C transactions in Moderna, Inc. stock. As of the latest transaction made, Broderick Brian C holds 15,000 shares of MRNA stock, worth $552,750. This represents 0.21% of its overall portfolio holdings.

Number of Shares
15,000
Previous 21,600 30.56%
Holding current value
$552,750
Previous $2.57 Million 60.94%
% of portfolio
0.21%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$63.64 - $125.14 $420,024 - $825,924
-6,600 Reduced 30.56%
15,000 $1 Million
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $1.02 Million - $1.39 Million
12,000 Added 125.0%
21,600 $2.3 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $462,768 - $607,728
4,800 Added 100.0%
9,600 $991,000
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $272,274 - $483,092
2,300 Added 92.0%
4,800 $862,000
Q3 2022

Nov 08, 2022

BUY
$118.07 - $194.18 $295,175 - $485,450
2,500 New
2,500 $296,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.